SprintRay
SprintRay is a 3D printing manufacturer for digital dentistry, with notable products like the Midas system for same-day restorations.
Secondary Market Price
How SprintRay Measures Up
To help you manage your SprintRay equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series D
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of SprintRay's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future SprintRay Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for SprintRay's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
SprintRay is a manufacturer of 3D printing ecosystems for dental professionals. Founded in 2014 by Amir Mansouri and Jing Zhang, the company develops and supplies dental 3D printers, post-processing devices, 3D printing materials, and software. This system enables dental practices to create a variety of appliances on-site, including retainers, clear aligners, indirect bonding trays, night guards, dental models, and ceramic crowns.
The company's focus is on expanding the applications of desktop 3D printing within dentistry. Recent announcements include the Midas system, which utilizes Digital Press Stereolithography to facilitate same-day, chairside dental restorations. SprintRay has also introduced new products like the Pro 2 printer and biomaterials such as Crown HT, a highly translucent, ceramic-filled hybrid resin. The company showcases its technology at industry events, having participated in AEEDC Dubai and with plans to attend the Dental VIP Summit in Chicago and RMDC 2026 in Denver.
- SoftBank Vision Fund
- Yiheng Capital
- ZWC Partners
- CD Capital
- Marathon Venture Partners
- Co-Founder, Amir Mansouri
- Co-Founder, Jing Zhang
- Co-Founder, Hossein Bassir
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is SprintRay worth joining?
Evaluating an offer from a private company like SprintRay requires analyzing the potential value of its equity, not just the salary. Tools like Prospect can help you compare your potential equity compensation against other opportunities to make an informed career decision.
What should I do with my SprintRay stock?
The right strategy for your stock depends entirely on your personal financial goals, risk tolerance, and tax situation. A platform like Prospect can build a customized plan for exercising options and selling shares that aligns with your specific circumstances.
Can you sell SprintRay stock?
As SprintRay is a private company, you can typically only sell shares during specific liquidity events, such as a tender offer or on a secondary market. Prospect provides tools and alerts to help you navigate these selling opportunities and decide which shares are most tax-optimal to sell.
How can I find the value of my SprintRay stock?
Determining the value of private stock is complex because it isn't publicly traded and the 409A valuation doesn't reflect its potential market price. You can use Prospect to get data-driven projections on your equity's future value based on models used by top venture capitalists.
What is SprintRay's equity worth?
The true worth of your equity is its net value after you account for exercise costs and taxes, which can significantly impact your final take-home amount. Prospect helps you calculate this net equity value by creating tax-optimized strategies for your specific holdings.
What is SprintRay's stock ticker symbol?
Because SprintRay is a private company, its stock is not traded on a public exchange and therefore does not have a ticker symbol. You can manage your private company shares using specialized platforms like Prospect, which are designed for pre-IPO equity.
Can I buy or sell SprintRay stock?
For employees, "buying" stock typically means exercising your vested options, while selling is usually restricted to company-approved windows like tender offers. Prospect offers personalized strategies to help you determine the best time to both exercise and sell your shares.
What is the criteria to buy or invest in SprintRay stock?
Deciding whether to exercise your stock options involves analyzing your personal finances, potential tax implications, and the company's growth prospects. Platforms like Prospect provide scenario modeling and diversification analysis to help you make a well-informed decision.
